$VGZ
VISTA GOLD CORP

2024 Q3 Form 10-Q Financial Statement

#000078332424000068 Filed on July 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 -$16.91M
YoY Change
Gross Profit $0.00 $16.91M
YoY Change
Gross Profit Margin
Selling, General & Admin $720.0K $763.0K
YoY Change 8.11% -13.1%
% of Gross Profit 4.51%
Research & Development $1.099M $645.0K
YoY Change 29.6% -5.43%
% of Gross Profit 3.81%
Depreciation & Amortization $14.00K $14.00K
YoY Change 40.0% 40.0%
% of Gross Profit 0.08%
Operating Expenses $1.833M -$15.49M
YoY Change 20.28% -1086.43%
Operating Profit -$1.833M $32.40M
YoY Change
Interest Expense $230.0K $163.0K
YoY Change 238.24% 132.86%
% of Operating Profit 0.5%
Other Income/Expense, Net $195.0K $146.0K
YoY Change 178.57% 117.91%
Pretax Income -$1.638M $15.63M
YoY Change 12.65% -1140.12%
Income Tax
% Of Pretax Income
Net Earnings -$1.638M $15.63M
YoY Change 12.65% -1140.12%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 $0.13
Diluted Earnings Per Share -$0.01 $0.12
COMMON SHARES
Basic Shares Outstanding 122.3M 121.8M
Diluted Shares Outstanding 122.3M 125.4M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.95M $20.23M
YoY Change 290.97% 237.87%
Cash & Equivalents $18.95M $20.23M
Short-Term Investments
Other Short-Term Assets $208.0K $334.0K
YoY Change -26.5% -2.34%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $19.16M $20.56M
YoY Change 273.46% 224.89%
LONG-TERM ASSETS
Property, Plant & Equipment $313.0K $260.0K
YoY Change 51.94% 50.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $69.00K $69.00K
YoY Change
Total Long-Term Assets $940.0K $412.0K
YoY Change -60.03% -82.23%
TOTAL ASSETS
Total Short-Term Assets $19.16M $20.56M
Total Long-Term Assets $940.0K $412.0K
Total Assets $20.10M $20.97M
YoY Change 168.64% 142.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $162.0K $190.0K
YoY Change 3.85% 245.45%
Accrued Expenses $917.0K $613.0K
YoY Change 16.37% -12.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.079M $803.0K
YoY Change 14.3% 5.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $21.00K $28.00K
YoY Change -46.15% -22.22%
Total Long-Term Liabilities $21.00K $28.00K
YoY Change -46.15% -22.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.079M $803.0K
Total Long-Term Liabilities $21.00K $28.00K
Total Liabilities $1.100M $831.0K
YoY Change 11.9% 4.66%
SHAREHOLDERS EQUITY
Retained Earnings -$458.5M -$456.8M
YoY Change -2.4% -2.44%
Common Stock $477.5M $477.0M
YoY Change 0.26% 0.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.00M $20.14M
YoY Change
Total Liabilities & Shareholders Equity $20.10M $20.97M
YoY Change 168.64% 142.52%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$1.638M $15.63M
YoY Change 12.65% -1140.12%
Depreciation, Depletion And Amortization $14.00K $14.00K
YoY Change 40.0% 40.0%
Cash From Operating Activities -$1.015M -$1.377M
YoY Change -7.31% 12.96%
INVESTING ACTIVITIES
Capital Expenditures $78.00K $31.00K
YoY Change 81.4%
Acquisitions
YoY Change
Other Investing Activities -$573.0K $9.476M
YoY Change
Cash From Investing Activities -$651.0K $9.445M
YoY Change 1413.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 395.0K 244.0K
YoY Change -56.43%
NET CHANGE
Cash From Operating Activities -1.015M -1.377M
Cash From Investing Activities -651.0K 9.445M
Cash From Financing Activities 395.0K 244.0K
Net Change In Cash -1.271M 8.312M
YoY Change 11.69% -1361.31%
FREE CASH FLOW
Cash From Operating Activities -$1.015M -$1.377M
Capital Expenditures $78.00K $31.00K
Free Cash Flow -$1.093M -$1.408M
YoY Change -3.95% 15.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0000783324
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2023 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-09025
dei Entity Registrant Name
EntityRegistrantName
VISTA GOLD CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A1
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0542444
dei Entity Address Address Line1
EntityAddressAddressLine1
8310 S Valley Hwy, Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Englewood
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80112
dei City Area Code
CityAreaCode
720
dei Local Phone Number
LocalPhoneNumber
981-1185
dei Security12b Title
Security12bTitle
Common Shares, no par value
dei Trading Symbol
TradingSymbol
VGZ
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
122289164
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20225000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6069000
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
334000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
446000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
20559000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
6515000
CY2024Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
83000
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
2146000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
260000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
204000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
69000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
69000
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
412000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
2419000
CY2024Q2 us-gaap Assets
Assets
20971000
CY2023Q4 us-gaap Assets
Assets
8934000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
190000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
190000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
613000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
749000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
803000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
939000
CY2023Q4 us-gaap Deferred Gain On Sale Of Property
DeferredGainOnSaleOfProperty
3000000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
44000
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
28000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3044000
CY2024Q2 us-gaap Liabilities
Liabilities
831000
CY2023Q4 us-gaap Liabilities
Liabilities
3983000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
122289164
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
121088494
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
476983000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
476354000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-456843000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-471403000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
20140000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4951000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20971000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8934000
CY2024Q2 us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
645000
CY2023Q2 us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
682000
us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
1410000
us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
1486000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
763000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
878000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2006000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2046000
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20000
CY2024Q2 vgz Gain Loss On Grant Of Royalty Interest In Mineral Titles
GainLossOnGrantOfRoyaltyInterestInMineralTitles
16909000
vgz Gain Loss On Grant Of Royalty Interest In Mineral Titles
GainLossOnGrantOfRoyaltyInterestInMineralTitles
16909000
vgz Gain Loss On Disposition Of Assets Net
GainLossOnDispositionOfAssetsNet
802000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
-15487000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1570000
us-gaap Operating Expenses
OperatingExpenses
-14269000
us-gaap Operating Expenses
OperatingExpenses
3552000
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
163000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
70000
us-gaap Investment Income Interest
InvestmentIncomeInterest
266000
us-gaap Investment Income Interest
InvestmentIncomeInterest
139000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-61000
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
146000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
67000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
291000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
78000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15633000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1503000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14560000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3474000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
15633000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1503000
us-gaap Net Income Loss
NetIncomeLoss
14560000
us-gaap Net Income Loss
NetIncomeLoss
-3474000
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121922034
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120637683
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121570013
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119843910
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125421848
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120637683
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124620981
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119843910
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8548000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
560000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
248000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1503000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7853000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4137000
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
191000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
179000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
15633000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
20140000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
10029000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1013000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-142000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
427000
us-gaap Net Income Loss
NetIncomeLoss
-3474000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7853000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4951000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
244000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-85000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
470000
us-gaap Net Income Loss
NetIncomeLoss
14560000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
20140000
us-gaap Profit Loss
ProfitLoss
14560000
us-gaap Profit Loss
ProfitLoss
-3474000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20000
us-gaap Share Based Compensation
ShareBasedCompensation
470000
us-gaap Share Based Compensation
ShareBasedCompensation
427000
vgz Gain Loss On Grant Of Royalty Interest In Mineral Titles
GainLossOnGrantOfRoyaltyInterestInMineralTitles
16909000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
900000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-112000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-195000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-152000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-163000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2793000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2995000
vgz Proceeds From Grant Of Royalty Interests In Mining Properties
ProceedsFromGrantOfRoyaltyInterestsInMiningProperties
17000000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
900000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
82000
vgz Payments To Develop Mineral Reserves
PaymentsToDevelopMineralReserves
1028000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16790000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
244000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1013000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
85000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
142000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
159000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
871000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14156000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2124000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6069000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8110000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20225000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5986000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5800000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5540000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
260000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5718000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5514000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
204000
CY2024Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
150000
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
152000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
463000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
597000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
613000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
749000
vgz Percentage Of Issued And Outstanding Common Shares For Stock Based Compensation Plan
PercentageOfIssuedAndOutstandingCommonSharesForStockBasedCompensationPlan
0.10
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
179000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
248000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
470000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
427000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1367000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.71
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y7M20D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
967000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.71
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
400000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.70
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y5M19D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
350000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.73
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
50000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.51
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y9M
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
50000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.51
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y9M
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121922034
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120637683
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121570013
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119843910
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3499814
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3050968
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125421848
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120637683
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124620981
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119843910
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 vgz Rule10b51 Arrangement Modified
Rule10b51ArrangementModified
false
CY2024Q2 vgz Non Rule10b51 Arrangement Modified
NonRule10b51ArrangementModified
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000783324-24-000068-index-headers.html Edgar Link pending
0000783324-24-000068-index.html Edgar Link pending
0000783324-24-000068.txt Edgar Link pending
0000783324-24-000068-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vgz-20240630.xsd Edgar Link pending
vgz-20240630x10q.htm Edgar Link pending
vgz-20240630x10q001.jpg Edgar Link pending
vgz-20240630xex23d1.htm Edgar Link pending
vgz-20240630xex23d2.htm Edgar Link pending
vgz-20240630xex23d3.htm Edgar Link pending
vgz-20240630x10q_htm.xml Edgar Link completed
vgz-20240630xex23d4.htm Edgar Link pending
vgz-20240630xex31d1.htm Edgar Link pending
vgz-20240630xex31d2.htm Edgar Link pending
vgz-20240630xex32d1.htm Edgar Link pending
vgz-20240630xex32d2.htm Edgar Link pending
vgz-20240630_cal.xml Edgar Link unprocessable
vgz-20240630_def.xml Edgar Link unprocessable
vgz-20240630_lab.xml Edgar Link unprocessable
vgz-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable